After Hours
$
10.50
Change
-0.12 -1.13%
Volume
Volume 87,013
May 16, 2022, 5:51 p.m.
Quotes are delayed by 20 min
Today's close
$ 10.31
$ 10.62
Change
+0.31 +3.01%
Day low
Day high
$10.10
$10.86

52 week low
52 week high
$6.51
$38.91

Market cap
$682.69M
Average volume
1.32M
P/E ratio
N/A
Rev. per Employee
$357,911
EPS
-4.90
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on DCPH
-
Deciphera Pharmaceuticals downgraded to hold from buy at Truist
- Tomi Kilgore
-
Deciphera Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus
- Tomi Kilgore
-
Deciphera Pharmaceuticals stock price target cut to $65 from $84 at Truist
- Tomi Kilgore
-
Deciphera Pharmaceuticals coverage resumed at Stifel with buy stock rating and $60 target price
- Tonya Garcia
-
Deciphera Pharmaceuticals started at buy with $75 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Callon, Fitbit, Genco Shipping, and Other 13D Filings
- Barron's Online
-
Deciphera Pharmaceuticals stock price target raised to $60 from $45 at SunTrust RH
- Tomi Kilgore
-
Deciphera Pharmaceuticals stock rockets 126% premarket after positive trial data for GIST treatment
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at buy with $42 stock price target at Deutsche Bank
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at outperform with $47 stock price target at Raymond James
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at buy with $60 stock price target at SunTrust RH
- Tomi Kilgore
-
Deciphera Pharmaceuticals started at overweight with $30 stock price target at J.P. Morgan
- Tomi Kilgore
Analyst Ratings
-
Deciphera Pharma Scores A Sell-Side Recommendation
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For February 16, 2018
- Benzinga.com
-
Benzinga's Top Upgrades, Downgrades For October 23, 2017
- Benzinga.com
Other News on DCPH
-
10-Q: DECIPHERA PHARMACEUTICALS, INC.
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings before Wednesday's open
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on DCPH
-
Deciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results
- BusinessWire - BZX
-
Deciphera Pharmaceuticals Inc. (DCPH) Climbs to Annual-High Share Price
- Investor Brand Network
-
Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com